Tenax Therapeutics, Inc. (TENX) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.67K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4.67K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | - | 100% | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 16.57M | 16.45M | 16.81M | 11.79M | 11.34M | 7.29M | -4.62M | 3.67M | 3.91M | 3.34M | -2.12M | -1.24M | 1.54M | 19.55M | -2.92M | -2.86M | -2.72M | 3.21M | -3.8M | -1.96M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 5.03M | 5.91M | 6.48M | 5.67M | 5.66M | 2.7M | 1.51M | 1.34M | 1.23M | 1.64M | 1.05M | 1.04M | 1.27M | 1.42M | 1.38M | 1.34M | 1.54M | 1.1M | 2.64M | 1.27M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 11.54M | 10.54M | 10.33M | 6.12M | 5.68M | 4.59M | 3.11M | 2.33M | 2.68M | 1.7M | 1.07M | 197.9K | 265.74K | 1.13M | 1.54M | 1.52M | 1.18M | 915.6K | 1.16M | 693.22K |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | -1000K | 0 | 0 | 0 | -1000K | -1000K | 0 | 1000K | -1000K | -1000K | -1000K | 1000K | -1000K | -1000K |
| Operating Income | -16.57M | -16.45M | -16.81M | -11.79M | -11.34M | -7.29M | 4.62M | -3.67M | -3.91M | -3.34M | 2.12M | 1.24M | -1.54M | -19.55M | 2.92M | 2.86M | 2.72M | -3.21M | 3.8M | 1.96M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -46.17% | -125.49% | -463.85% | -221.22% | -190.05% | -118.35% | 118.14% | -396.97% | -153.92% | 82.91% | -27.42% | -56.81% | -156.63% | -508.72% | -23.27% | 45.68% | -88.55% | -13.36% | 270.88% | -8.37% |
| EBITDA | -16.57M | -15.54M | -15.8M | -10.85M | -10.41M | -6.27M | -3.95M | -3.57M | -3.79M | -3.34M | 2.12M | 1.24M | -1.54M | -19.55M | 2.95M | 2.89M | 2.75M | -3.21M | 3.83M | 1.99M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -59.23% | -147.96% | -299.68% | -204.18% | -174.54% | -87.85% | -286.66% | -388.24% | -146.4% | 82.93% | -28.09% | -57.19% | -156.02% | -508.88% | -23.05% | 45.21% | -88.45% | -14.51% | 274.32% | -8.39% |
| D&A (Non-Cash Add-back) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.67K | 969 | 1K | 895 | 1.34K | 28.51K | 28.01K | 27.61K | 1.08K | 26.27K | 25.66K |
| EBIT | -16.57M | -15.54M | -15.8M | -10.85M | -10.41M | -6.27M | -3.95M | -3.57M | -3.79M | -3.22M | -1.97M | -1.1M | -1.4M | -2.55M | -2.92M | -2.86M | -2.72M | -2.01M | -3.8M | -1.72M |
| Net Interest Income | 861K | 918K | 1.02M | 954K | 930K | 1.03M | 658.41K | 95.69K | -7.96K | -2.15K | 145.4K | 130.73K | -7.35K | 0 | -372 | -1.42K | -2.59K | 0 | 0 | -336 |
| Interest Income | 861K | 918K | 1.02M | 954K | 930K | 1.03M | 664.72K | 104.88K | 0 | 0 | 150.74K | 139.86K | 0 | 0 | 0 | 63 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 6.31K | 9.19K | 7.96K | 2.15K | 5.34K | 9.13K | 7.35K | 0 | 372 | 1.48K | 2.59K | 0 | 0 | 336 |
| Other Income/Expense | 857K | 909K | 1M | 945K | 930K | 1.03M | -8.58M | 96K | 110K | 115.34K | -4.09M | -2.34M | 132.71K | 17M | -5.83M | -5.72M | -5.44M | 1.24K | -7.6M | -3.68M |
| Pretax Income | -15.72M | -15.54M | -15.8M | -10.85M | -10.41M | -6.27M | -3.96M | -3.58M | -3.8M | -3.23M | -1.97M | -1.11M | -1.41M | -2.55M | -2.92M | -2.86M | -2.72M | -3.21M | -3.8M | -1.72M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -15.72M | -15.54M | -15.8M | -10.85M | -10.41M | -6.27M | -3.96M | -3.58M | -3.8M | -3.23M | -1.97M | -1.11M | -1.41M | -2.55M | -2.92M | -2.86M | -2.72M | -3.21M | -3.8M | -1.72M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -51% | -147.96% | -299.04% | -203.41% | -173.97% | -94.29% | -100.84% | -223.14% | -170.05% | -26.55% | 32.39% | 61.33% | 48.31% | 20.61% | 23.22% | -66.63% | 88.54% | -13.46% | -71.08% | 20.01% |
| Net Income (Continuing) | -15.72M | -15.54M | -15.8M | -10.85M | -10.41M | -6.27M | -3.96M | -3.58M | -3.8M | -3.23M | -1.97M | -1.11M | -1.41M | -2.55M | -2.92M | -2.86M | -2.72M | -3.21M | -3.8M | -1.72M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.35 | -0.39 | -0.40 | -0.27 | -0.28 | -0.18 | -0.19 | -1.83 | -3.12 | -10.81 | -6.61 | -4.00 | -12.10 | -99.44 | -177.60 | -181.60 | -172.80 | -203.38 | -241.18 | -159.56 |
| EPS Growth % | -25% | -116.67% | -110.53% | 85.25% | 91.03% | 98.33% | 97.13% | 54.25% | 74.21% | 89.13% | 96.28% | 97.8% | 93% | 51.11% | 26.36% | -13.81% | 93.41% | 28.13% | 16.26% | 56.64% |
| EPS (Basic) | -0.35 | -0.39 | -0.40 | -0.27 | -0.28 | -0.18 | -0.19 | -1.83 | -3.12 | -10.81 | -6.61 | -4.00 | -12.10 | -101.79 | -177.60 | -181.60 | -172.80 | -214.04 | -241.18 | -159.56 |
| Diluted Shares Outstanding | 45.23M | 39.22M | 39.74M | 39.57M | 36.58M | 15.27M | 21.16M | 1.96M | 1.22M | 248.45K | 298.28K | 276.45K | 116.26K | 18.39K | 16.46K | 15.75K | 15.75K | 12.86K | 15.75K | 10.76K |
| Basic Shares Outstanding | 45.23M | 39.22M | 39.74M | 39.57M | 36.58M | 15.27M | 21.16M | 1.96M | 1.22M | 248.45K | 298.28K | 276.45K | 116.26K | 18.39K | 16.46K | 15.75K | 15.75K | 12.86K | 15.75K | 10.76K |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |